Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05829733

6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis

6-month Evaluation of the Efficacy and Safety of Synolis VA 80/160 in the Treatment of Symptomatic Hip Osteoarthritis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Aptissen SA · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multicenter, independent study of Synolis VA 80/160 over a period of 6 months

Conditions

Interventions

TypeNameDescription
DEVICESYNOLIS VA 80/160SYNOLIS VA 80/160 (hyaluronic acid 80 mg, sorbitol 160 mg)

Timeline

Start date
2024-05-27
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2023-04-26
Last updated
2025-12-12

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05829733. Inclusion in this directory is not an endorsement.